Valisure is an online analytical pharmacy that chemically tests every single batch of all the medications and supplements they sell. You may or may not have heard of them, but they’re making a big splash in the name of pharmaceuticals.
One of the analytical pharmacy’s main goals is to maintain transparency and consistency with their products and the products they provide testing for. From their website, “We’ve all had the experience of buying a bad batch of produce from a supermarket, but you can usually tell when food is bad by smell, taste or appearance. But a bad batch of meds tends to look, taste and smell exactly like a good one – only reliable way to tell is by chemical analysis and with a Valisure Certificate of Analysis (COA).”
Valisure provides drugs that pass their tests with their Certificate of Analysis (COA). The pharmacy uses the following to test drugs:
The company alleges that there are roughly three drug recalls in the United States every day. That’s a whole lot of bad drugs being pulled from America’s pharmacies.
Valisure’s mission is “to bring transparency and increased quality to the pharmaceutical industry, and to deliver these benefits direct to consumers. We hope to achieve this through focusing on patient advocacy, consumer protection, and performing advanced research and development.”
The company came to be when founders Adam Clark-Joseph and David Light came together when Adam endured severe challenges as a result of pharmaceutical batch variability. Adam relied on anticonvulsant medication to maintain daily regularity.
When Adam and David dug deeper into the issue, they realized that batch variability was a sizable problem within the pharmaceutical industry, and they were determined to do something about it. Together, the two conjoined a dream team of like-minded scientists and pharmacy masters to establish and implement a remedy. The outcome was Valisure, an analytical pharmacy that is committed to stopping the spread of low-quality medications to people who will suffer adverse effects as a result.
Since Valisure is so committed to making sure Americans receive only the highest quality pharmaceuticals on the market, it comes as no surprise that the company alerted the Food and Drug Administration (FDA) when their tests found N-Nitrosodimethylamine (NDMA) present within the active ingredient, ranitidine, in the heartburn relief medication, Zantac.
It was on September 13th, 2019 that the company filed a petition with the FDA requesting that the agency recall all products containing ranitidine. The pharmaceutical company found that NDMA levels were the result of “inherent instability” within the ranitidine molecule.
The company claims that all medications containing ranitidine have the potential to generate unsafe levels of NDMA in the body. David Light, the CEO of Valisure further provides that, “There’s no acceptable cancer risk for a drug like this.”
Dr. Jon Ernstoff, who has been practicing gastroenterology for over 41 years shares his concerns, “This study is really important to disseminate to the public because so many patients are taking these medications without medical guidance.”
If you have been affected by the heartburn relieving medication, Zantac, our attorneys at Goodman Acker are here to help. Our firm has extensive experience in the field of product liability law, and our attorneys have helped many other people just like you. Don’t hesitate to contact our firm with your case right away. Don’t wait; it’s your health on the line!
Call Goodman Acker today at (248) 793-2010 if you’ve been taking Zantac or other ranitidine medications for heartburn relief.
We have been helping accident injury victims in Michigan win the maximum settlement for their injuries for 25+ years.
Take a look at what some of our previous clients have to say about the high caliber of the services we provide.
If you have been wrongly injured, we would be happy to review the specific details of your case to determine how we can help.